Allergy shots for dust mites to reduce allergy symptoms
Part of Ear, nose & throat, Immune system & allergy, Infections, Lungs & breathing clinical trials.
This trial tests a dust-mite allergy extract (“allergy shots”) to see if it safely reduces symptoms from dust-mite–driven hay fever (rhinitis/rhinoconjunctivitis), and possibly asthma symptoms. If you qualify, it may help your immune system tolerate dust mites better over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You (or your guardian) can sign consent, and you’re between ages 12 and 60
- Your allergy is confirmed to dust mites (D. pteronyssinus and/or D. farinae) using allergy tests
- Your nasal/eye allergy symptoms are at least moderate, based on your symptom-and-medicine score
- If you have asthma, it must be stable and not severe/uncontrolled (lung function and control will be checked)
- You are able to follow the treatment schedule and use a smartphone to track symptoms
- If you can become pregnant, you must have a negative pregnancy test and use reliable birth control
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if allergy shots (allergen-specific immunotherapy) can reduce symptoms of moderate to severe dust mite allergy. You will be in a room that exposes you to dust mites to see how well the treatment works, compared to a placebo.
This trial tests a new way of giving allergy shots directly into the tonsils to treat dust mite allergies that cause runny nose, sneezing, and itchy eyes. It aims to see if this method is safer and works better than standard treatment.
This Phase 3 study tests whether dust-mite allergy treatment (likely allergy shots) can reduce allergy symptoms and improve safety. It focuses on people whose nose/eye allergy is triggered by house dust mites and who may also have controlled asthma.
This trial tests allergy shots for children with dust mite allergies causing rhinitis or asthma. It aims to see if guiding treatment with detailed allergy testing leads to better results.
This trial tests allergy drops placed under the tongue to treat allergic rhinitis caused by house dust mites. It aims to see if the drops can safely reduce symptoms like sneezing and stuffy nose.
This trial tests an under-the-tongue tablet for people with dust mite allergies causing moderate to severe nasal symptoms or mild-to-moderate asthma. The goal is to see if it improves symptoms and can replace or reduce the need for allergy medicines.
Hear when a new Allergic Rhinitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.